…Obesity drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) produce substantial weight loss for patients but do …
Wegovy
This drug is selected. Its supporting articles are shown below.
Articles mentioning Wegovy
12 articles · page 1 of 1…Ischaemic optic neuropathy was strongly associated with semaglutide, particularly Wegovy, in over 30 million FAERS reports. Signals…
… which is used for obesity treatment (ROR 74.89), compared with Ozempic which is used for diabetes (ROR 18.81). These findings add to a…
…cation recently linked to GLP-1 receptor agonists, particularly semaglutide. Using over 30 million reports from the FDA Adverse Event Repor…
…ks.2 However, no real-world data exist investigating the use of tirzepatide in patients with type 2 diabetes mellitus (T2DM) and MASLD to u…
…GPs will be able to prescribe semaglutide (Wegovy) to overweight patients who have had a heart attack or …
…ucagon-like peptide-1 (GLP-1) receptor agonist weight loss drug Wegovy (semaglutide), saying that its first direct to consumer TV adve…
… now in use—semaglutide (Wegovy), produced by Novo Nordisk, and tirzepatide (Mounjaro), produced by Eli Lilly—have been shown in clinical t…
…Semaglutide, marketed as Ozempic, Wegovy and Rybelsus, has rapidly become o…
… a daily pill version of Novo Nordisk’s injectable obesity drug Wegovy (semaglutide), opening the door to even more patients taking it…
…on of glucagon-like peptide-1 receptor (GLP-1) agonists such as semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) needs to…
…ical analysis showed that the vial contained insulin instead of semaglutide, therefore leading to severe hypoglycaemia. This case highlight…